NCT01991873View on ClinicalTrials.gov

Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

387

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

February 18, 2023

Study Completion Date

February 18, 2023

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Maintenance Chemotherapy

DRUG

Panitumumab (Within maintenance phase)

DRUG

mFOLFOX6 (Within re-induction phase)

DRUG

Panitumumab (Within re-induction phase)

Trial Locations (2)

26389

Zentrum für Tumorbiologie und Integrative Medizin, Klinikum Wilhelmshaven, Wilhelmshaven

52249

St.-Antonius-Hospital Eschweiler, Eschweiler

Sponsors

Collaborators (2)

ClinAssess GmbH
Amgen
All Listed Sponsors
collaborator

ClinAssess GmbH

INDUSTRY

collaborator

Amgen

INDUSTRY

lead

AIO-Studien-gGmbH

OTHER